Financial Results for the Quarter ended June 30, 2025.
Financial Results For The Quarter Ended June 30, 2025.
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Board Meeting Outcome for Financial Results For The Quarter Ended June 30, 2025.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 16 2025
- Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2025.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 14 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Later from Venmax Drugs & Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 24 2025
- Board Meeting Intimation for Allotment Of Equity Shares Pursuant To Conversion Of Convertible Equity Share Warrants.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 08 2025
- Board Meeting Outcome for Outcome Of Board Meeting For Conversion Of Share Warrants And Allotment Of Equity Shares
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals